Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Decoy Therapeutics Inc (DCOY) vs Trevena, Inc. (TRVN)

Decoy Therapeutics Inc and Trevena, Inc. are both Biotechnology companies. Decoy Therapeutics Inc and Trevena, Inc. are of similar size ($2.0M and $1.8M). Trevena, Inc. has negative trailing earnings, so its P/E is not meaningful; Decoy Therapeutics Inc trades at 0.0×. Decoy Therapeutics Inc grew revenue faster over the last twelve months: −60.5% against −83.0%. Decoy Therapeutics Inc has the higher net margin (−698.8% vs −6,233.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Decoy Therapeutics Inc leads on 9 and Trevena, Inc. on 7.

Valuation

Metric DCOY TRVN Biotechnology median
P/E 0.02 n/m 7.88
P/S 0.79 0.02 11.47
P/B 0.38 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.42 n/m 0.74
EV/Sales (2.99) 35.05 10.73
Earnings yield 5,960.59% (470,400.00%) (28.84%)
Free cash flow yield (637.25%) (318,077.37%) (23.03%)

Profitability

Metric DCOY TRVN Biotechnology median
Gross margin 10.57% (190.29%) 65.16%
Operating margin (706.88%) (5,879.85%) 0.00%
Net margin (698.79%) (6,233.70%) 0.00%
Free cash flow margin (432.43%) (4,961.72%) 0.00%
Return on equity (827.77%) 344.49% (57.72%)
Return on assets (278.04%) (105.83%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric DCOY TRVN Biotechnology median
Revenue growth (TTM) (60.49%) (82.97%) 5.64%
EPS growth (last fiscal year) (85.66%) 58.37% —
Revenue growth, 5-year CAGR 12.73% (11.43%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DCOY TRVN Biotechnology median
Debt to equity 0.00 (1.41) 0.00
Current ratio 1.83 2.42 4.73
Net debt to EBITDA 0.85 0.06 0.96

Dividend

Metric DCOY TRVN Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric DCOY TRVN Biotechnology median
Market cap 1.99m 1.81m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack